## GE HealthCare Partners with DeepHealth to Revolutionize Breast Cancer Screening with AI
GE HealthCare Technologies Inc. (GEHC) has announced a strategic collaboration with DeepHealth, a subsidiary of RadNet, Inc. (RDNT), to advance the use of artificial intelligence (AI) in medical imaging. This partnership aims to develop innovative SmartTechnology solutions that leverage AI to improve image interpretation, reporting, clinical collaboration, and operational efficiency within the field of breast cancer screening.
Under the agreement, GE HealthCare will distribute DeepHealth’s SmartMammo and other AI-driven technologies to imaging providers across the United States. SmartMammo is a cutting-edge AI solution designed to enhance the accuracy and efficiency of mammogram analysis. By incorporating AI into the screening process, SmartMammo assists radiologists in identifying potentially suspicious lesions, ultimately leading to earlier detection and improved patient outcomes.
Beyond SmartMammo, GE HealthCare and DeepHealth plan to explore further collaboration on SmartTechnology solutions across various imaging modalities and clinical domains. The goal is to broaden access to AI-powered workflows, ultimately improving efficiency and enhancing patient care.
Improving Breast Cancer Detection and Diagnosis
This collaboration aims to significantly enhance breast cancer screening by integrating AI-driven clinical imaging support. This integration will improve the detection and diagnosis of breast cancer during the crucial early stages of treatment. Early detection is critical for increasing treatment success rates and improving patient outcomes.
Smart Alerts: Enhancing Workflow Efficiency
The collaboration will also incorporate Smart Alerts, a DeepHealth workflow solution integrated with Senographe Pristina, a GE HealthCare mammography system. This feature utilizes rapid AI processing to quickly identify potentially suspicious lesions, alerting imaging sites within minutes. This rapid feedback loop allows for same-day diagnostic exams, improves follow-up compliance, and ultimately reduces anxiety for women with potentially concerning findings.
Investor Implications
Investors interested in gaining exposure to this growing sector can consider the Spinnaker ETF Series Langar Global HealthTech ETF (LGHT) and the Invesco S&P Spin-Off ETF (CSD). These ETFs offer diversified exposure to the healthtech industry, including companies like GE HealthCare and DeepHealth.
Positive Market Reaction
The announcement of this strategic partnership has been met with positive market sentiment. GEHC shares rose 0.31% to $86.21 in premarket trading on Monday, indicating investor confidence in the potential of this collaboration to drive innovation and growth in the medical imaging space.
A Promising Future for AI in Breast Cancer Screening
Roland Rott, President & Chief Executive Officer of Imaging for GE HealthCare, emphasized the potential of AI in revolutionizing breast care. “As we look to make more personalized, patient-centered breast care a reality – AI continues to show great promise in breast cancer screening from early detection and risk prediction, to reduced callbacks and more efficient workflows for breast imaging providers.” This collaboration signifies a major step towards leveraging AI to improve breast cancer screening and enhance patient outcomes.
